EGFR and metastatic colorectal cancer: The HER1-binding arm in TsAb2v2 and TsAb3v1 is derived from the glycoengineered HER1-antibody Imgatuzumab (GA201), which was in a Phase II trial in patients with metastatic colorectal cancer.